Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERD

Summary

The purpose of this study is to evaluate the efficacy and safety of Ilaprazole 20 mg in patients with non-erosive reflux disease. This study intends to demonstrate the clinical superiority of Ilaprazole 20 mg to placebo administered once daily for 4 weeks.

Timeline

Start

2018-10-31

Primary completion

2020-02-25

Completion

2020-02-25

Drugs

Indications